Department About Boehringer Ingelheim Animal Health Partnering Biopharma Science & Innovation Human Health All Departments Therapeutic Area Cardio-Renal-Metabolic Diseases CNS Diseases Immunology Oncology Respiratory Diseases Retinal Diseases All Therapeutic Areas Indication Stroke Obesity NASH COPD & Asthma Atrial Fibrilation Hypertension BOPD (Borderline) Lung Cancer Gastrointestinal Cancer Diabetes Heart Failure Depression Kidney Diseases Schizophrenia GPP Melanoma All Indications Veterinary Category Pets Poultry Ruminants Horses Veterinary Public Health Swine All Veterinary Categories Reset all filters FDA approves Jardiance® for treatment of adults with chronic kidney disease September 21, 2023 FDA approves Jardiance® for treatment of adults with chronic kidney disease Read more
FDA approves Jardiance® for treatment of adults with chronic kidney disease September 21, 2023 FDA approves Jardiance® for treatment of adults with chronic kidney disease Read more
